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Identity 
Other names: CD73, E5NT, NT, NT5, NTE, eN, eNT 




Two transcript variants encoding different isoforms 
have been found for this gene.  
Variant 1 represents the longer transcript and encodes 
the longer isoform 1, 9 exons, transcript length 3548 
bps, translation length 574 residues; variant 2 lacks an 
alternate in-frame exon compared to variant 1, 8 exons, 




There are two isoforms of NT5E. 5'-nucleotidase 
isoform 1 preproprotein, 574 amino acids; 5'-
nucleotidase isoform 2 preproprotein, 524 amino acids. 
Isoform 2 has the same N- and C-termini but is shorter 
compared to isoform 1. 
The NT5E preproprotein is further processed into a 
mature form, which consists of a dimer of 2 identical 
70-kD subunits bound by a glycosyl phosphatidyl 
inositol linkage at its C-terminus to the external face of 
the plasma membrane. 
Expression 
CD73 is a cell surface enzyme found in most  
tissues and many cell types including subsets of 
lymphocytes, macrophages, dendritic cells, endothelial 
cells and epithelial cells.  
Hypoxia induces CD73 mRNA, protein expression and 
increases CD73 activity in mouse microvascular 
endothelial cells.  
Particularly, CD73 is highly expressed in many human 
solid tumors, and its elevated expression and activity 
are associated with tumor invasiveness and metastasis 
and with shorter patient survival.  
The RNA expression and enzyme activity of CD73 are 
variable in different breast cancer cell lines. For more 




CD73 is an ectoenzyme (ecto-50-nucleotidase, EC 
3.1.3.5).  
It catalyzes conversion of AMP to adenosine. 
Adenosine exerts its effects via adenosine receptor A1, 
adenosine receptor A2A, adenosine receptor A2B and 
adenosine receptor A3. 
CD73 has many physiological roles, such as regulation 
of barrier function, adaptation to hypoxia, ischemic 
preconditioning, anti-inflammation, leukocyte 
extravasation. 
Expression and activity of CD73 on cancer cells is 
associated with poor prognosis and may promote 
metastasis.  
CD73 facilitates the adhesion, migration, invasion of 
human breast cancer cells and proliferation of glioma 
cells and these process are dependent upon the 
enzyme's production of adenosine. 
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The NT5E gene is located on the long (q) arm of chromosome 6 between positions 14 and 21. More precisely, the NT5E gene is located 





Deregulation of NT5E expression in melanoma occurs 
via epigenetic changes in the NT5E CpG island. 
Confirmation of the results in larger clinical series 
would support the candidacy of NT5E as a clinical 
biomarker in melanoma, which could be applied in 
both primary and relapsed disease. Inhibition of NT5E 
may have therapeutic potential in melanoma, 
particularly in patients with more aggressive disease 
metastasis to viscera or the brain. 
Colorectal cancer 
Note 
CD73 expression in colorectal cancer is significantly 
higher than in normal colorectal tissues. 
Prognosis 
Patients with high expression of CD73 had a poorer 
overall survival rate compared with patients with low 
expression of CD73 in both cohorts. High expression of 
CD73 can be an independent and useful biomarker for 
predicting the poor survival of patients with colorectal 
cancer. 
Chronic lymphocytic leukemia 
Note 
CD73-generated extracellular adenosine in chronic 
lymphocytic leukemia increases cytoplasmic cAMP 
levels by activation of the ADO receptors, inhibiting 
chemotaxis and limiting spontaneous drug-induced 
apoptosis of chronic lymphocytic leukemia cells. 
Glioma 
Note 
Adenosine induced an increase in glioma cell adhesion. 
Ecto-5'-NT/CD73, an important producer of 
extracellular adenosine, may modulate glioma cell 




CD73 plays an important role in breast cancer growth 
by affecting cell cycle progression and apoptosis. CD73 
overexpression increased cell viability and promoted 
cell cycle progression, depending on its enzyme 
activity.  
CD73 may facilitate the adhesion, migration and 
invasion of human breast cancer cells through its 
enzyme activity of generating adenosine. 
Tumor-derived CD73 is a mechanism of tumor immune 
escape and tumor metastasis, and targeted therapy 
against CD73 can trigger adaptive anti-tumor immunity 
and inhibit metastasis of breast cancer. 
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